Skip to main content

Advertisement

SpringerLink
Log in

Personalized medicine and the genotype–phenotype dilemma

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mendel, G. (1866). Experiments in plant hybridization. Verhandlungen des naturforschenden Vereines in Brunn, bd IV fur das Jahr 1865, Abhandlungen, pp 3–47.

  2. Garrod, A. E. (1923). Inborn errors of metabolism (2nd ed.). Oxford: Oxford University Press.

    Google Scholar 

  3. Watson, J. D., & Crick, F. H. (1953). Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature, 171, 737–738.

    Article  PubMed  CAS  Google Scholar 

  4. Jervell, A., & Lange-Nielsen, F. (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal, 54, 59–68.

    Article  PubMed  CAS  Google Scholar 

  5. Romano, C., Gemme, G., & Pongiglione, R. (1963). Aritmie cardiache rare in età pediatrica. Clinical Pediatrics, 45, 656–683.

    CAS  Google Scholar 

  6. Ward, O. C. (1964). A new familial cardiac syndrome in children. J Irish Med Assoc, 54, 103–106.

    CAS  Google Scholar 

  7. Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., et al. (2003). Risk stratification in the long-QT syndrome. The New England Journal of Medicine, 348, 1866–1874.

    Article  PubMed  Google Scholar 

  8. Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: Clinical impact. Circulation, 99, 529–533.

    PubMed  CAS  Google Scholar 

  9. Collins, F. S., Drumm, M. L., Cole, J. L., Lockwood, W. K., Vande Woude, G. F., & Iannuzzi, M. C. (1987). Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science, 235, 1046–1049.

    Article  PubMed  CAS  Google Scholar 

  10. Geisterfer-Lowrance, A. A., Kass, S., Tanigawa, G., Vosberg, H. P., McKenna, W., Seidman, C. E., et al. (1990). A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell, 62, 999–1006.

    Article  PubMed  CAS  Google Scholar 

  11. The International HapMap Consortium. (2005). A haplotype map of the human genome. Nature, 437, 1299–1320.

    Article  Google Scholar 

  12. The International HapMap Consortium. (2007). A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851–861.

    Article  Google Scholar 

  13. Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. The New England Journal of Medicine, 363, 166–176.

    Article  PubMed  CAS  Google Scholar 

  14. Milan, D. J., Lubitz, S. A., Kaab, S., & Ellinor, P. T. (2010). Genome-wide association studies in cardiac electrophysiology: Recent discoveries and implications for clinical practice. Heart Rhythm, 7, 1141–1148.

    Article  PubMed  Google Scholar 

  15. Arking, D. E., Pfeufer, A., Post, W., Kao, W. H., Newton-Cheh, C., Ikeda, M., et al. (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nature Genetics, 38, 644–651.

    Article  PubMed  CAS  Google Scholar 

  16. Pfeufer, A., Sanna, S., Arking, D. E., Muller, M., Gateva, V., Fuchsberger, C., et al. (2009). Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nature Genetics, 41, 407–414.

    Article  PubMed  CAS  Google Scholar 

  17. Newton-Cheh, C., Eijgelsheim, M., Rice, K. M., de Bakker, P. I. W., Yin, X., Estrada, K., et al. (2009). Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature Genetics, 41, 399–406.

    Article  PubMed  CAS  Google Scholar 

  18. Kao, W. H., Arking, D. E., Post, W., Rea, T. D., Sotoodehnia, N., Prineas, R. J., et al. (2009). Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation, 119, 940–951.

    Article  PubMed  CAS  Google Scholar 

  19. Crotti, L., Monti, M. C., Insolia, R., Peljto, A., Goosen, A., Brink, P. A., et al. (2009). NOS1AP is a genetic modifier of the long-QT syndrome. Circulation, 120, 1657–1663.

    Article  PubMed  CAS  Google Scholar 

  20. Tomas, M., Napolitano, C., De, G. L., Bloise, R., Subirana, I., Malovini, A., et al. (2010). Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. Journal of the American College of Cardiology, 55, 2745–2752.

    Article  PubMed  CAS  Google Scholar 

  21. Milan, D. J., Kim, A. M., Winterfield, J. R., Jones, I. L., Pfeufer, A., Sanna, S., et al. (2009). A drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation, 120, 553–559.

    Article  PubMed  Google Scholar 

  22. Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature, 448, 353–357.

    Article  PubMed  CAS  Google Scholar 

  23. Kaab, S., Darbar, D., van Noord, C., Dupuis, J., Pfeufer, A., Newton-Cheh, C., et al. (2009). Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. European Heart Journal, 30, 813–819.

    Article  PubMed  Google Scholar 

  24. Mommersteeg, M. T. M., Brown, N. A., Prall, O. W. J., de Gier-de Vries, C., Harvey, R. P., Moorman, A. F. M., et al. (2007). Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circulation Research, 101, 902–909.

    Article  PubMed  CAS  Google Scholar 

  25. Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H., & Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proceedings of the National Academy of Sciences of the United States of America, 107, 9753–9758.

    Article  PubMed  CAS  Google Scholar 

  26. Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., et al. (2009). A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nature Genetics, 41, 876–878.

    Article  PubMed  CAS  Google Scholar 

  27. Ellinor, P. T., Lunetta, K. L., Glazer, N. L., Pfeufer, A., Alonso, A., Chung, M. K., et al. (2010). Common variants in KCNN3 are associated with lone atrial fibrillation. Nature Genetics, 42, 240–244.

    Article  PubMed  CAS  Google Scholar 

  28. Body, S. C., Collard, C. D., Shernan, S. K., Fox, A. A., Liu, K. Y., Ritchie, M. D., et al. (2009). Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet, 2, 499–506.

    Article  PubMed  CAS  Google Scholar 

  29. Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010). Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. Journal of the American College of Cardiology, 55, 747–753.

    Article  PubMed  CAS  Google Scholar 

  30. Rowan, S. B., Estrada, J. C., Stubblefield, T., Kucera, G., Carter, S., Roden, D. M., et al. (2009). A single nucleotide polymorphism at 4q25 associated with atrial fibrillation modulates symptomatic response to antiarrhythmic drug therapy. Heart Rhythm, 6, PO04-7.

    Google Scholar 

  31. Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U., Helgadottir, A., Gschwendtner, A., et al. (2008). Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Annals of Neurology, 64, 402–409.

    Article  PubMed  Google Scholar 

  32. Lubitz, S. A., Sinner, M. F., Lunetta, K. L., Makino, S., Pfeufer, A., Rahman, R., et al. (2010). Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation, 122, 976–984.

    Article  PubMed  CAS  Google Scholar 

  33. Bezzina, C. R., Pazoki, R., Bardai, A., Marsman, R. F., de Jong, J. S., Blom, M. T., et al. (2010). Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nature Genetics, 42, 688–691.

    Article  PubMed  CAS  Google Scholar 

  34. Holm, H., Gudbjartsson, D. F., Arnar, D. O., Thorleifsson, G., Thorgeirsson, G., Stefansdottir, H., et al. (2010). Several common variants modulate heart rate, PR interval and QRS duration. Nature Genetics, 42, 117–122.

    Article  PubMed  CAS  Google Scholar 

  35. Chambers, J. C., Zhao, J., Terracciano, C. M. N., Bezzina, C. R., Zhang, W., Kaba, R., et al. (2010). Genetic variation in SCN10A influences cardiac conduction. Nature Genetics, 42, 149–152.

    Article  PubMed  CAS  Google Scholar 

  36. Pfeufer, A., van Noord, C., Marciante, K. D., Arking, D. E., Larson, M. G., Smith, A. V., et al. (2010). Genome-wide association study of PR interval. Nature Genetics, 42, 153–159.

    Article  PubMed  CAS  Google Scholar 

  37. Denny, J. C., Ritchie, M. D., Crawford, D. C., Schildcrout, J. S., Ramirez, A. H., Pulley, J. M., et al. (2010). Identification of genomic predictors of atrioventricular conduction: Using electronic medical records as a tool for genome science. Circulation, 122, 2016–2021.

    Article  PubMed  Google Scholar 

  38. Sotoodehnia, N., Isaacs, A., de Bakker, P. I., Dorr, M., Newton-Cheh, C., Nolte, I. M., et al. (2010). Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics, 42, 1068–1076.

    Article  PubMed  CAS  Google Scholar 

  39. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature, 461, 747–753.

    Article  PubMed  CAS  Google Scholar 

  40. Shuldiner, A. R., O'Connell, J. R., Bliden, K. P., Gandhi, A., Ryan, K., Horenstein, R. B., et al. (2009). Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. Journal of the American Medical Association, 302, 849–857.

    Article  PubMed  CAS  Google Scholar 

  41. Veenstra, D. L., You, J. H., Rieder, M. J., Farin, F. M., Wilkerson, H. W., Blough, D. K., et al. (2005). Association of vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenetics and Genomics, 15, 687–691.

    Article  PubMed  CAS  Google Scholar 

  42. Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., et al. (2008). A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood, 112, 1022–1027.

    Article  PubMed  CAS  Google Scholar 

  43. Takeuchi, F., McGinnis, R., Bourgeois, S., Barnes, C., Eriksson, N., Soranzo, N., et al. (2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genetics, 5, e1000433.

    Article  PubMed  Google Scholar 

  44. Roden, D. M., & Brown, N. J. (2001). Preprescription genotyping: not yet ready for prime time, but getting there. Circulation, 103, 1608–1610.

    PubMed  CAS  Google Scholar 

  45. Collins, F. (2009). Opportunities and challenges for the NIH—an interview with Francis Collins. Interview by Robert Steinbrook. The New England Journal of Medicine, 361, 1321–1323.

    Article  PubMed  Google Scholar 

  46. Pepe, M. S., Janes, H., Longton, G., Leisenring, W., & Newcomb, P. (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology, 159, 882–890.

    Article  PubMed  Google Scholar 

  47. Darbar, D., Herron, K. J., Ballew, J. D., Jahangir, A., Gersh, B. J., Shen, W. K., et al. (2003). Familial atrial fibrillation is a genetically heterogeneous disorder. Journal of the American College of Cardiology, 41, 2185–2192.

    Article  PubMed  Google Scholar 

  48. Ellinor, P. T., Yoerger, D. M., Ruskin, J. N., & Macrae, C. A. (2005). Familial aggregation in lone atrial fibrillation. Human Genetics, 118, 179–184.

    Article  PubMed  Google Scholar 

  49. Friedlander, Y., Siscovick, D. S., Weinmann, S., Austin, M. A., Psaty, B. M., Lemaitre, R. N., et al. (1998). Family history as a risk factor for primary cardiac arrest. Circulation, 97, 155–160.

    PubMed  CAS  Google Scholar 

  50. Jouven, X., Desnos, M., Guerot, C., & Ducimetiere, P. (1999). Predicting sudden death in the population: The Paris Prospective Study I. Circulation, 99, 1978–1983.

    PubMed  CAS  Google Scholar 

  51. Dekker, L. R. C., Bezzina, C. R., Henriques, J. P. S., Tanck, M. W., Koch, K. T., Alings, M. W., et al. (2006). Familial sudden death is an important risk factor for primary ventricular fibrillation: A case–control study in acute myocardial infarction patients. Circulation, 114, 1140–1145.

    Article  PubMed  Google Scholar 

  52. Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272–276.

    Article  PubMed  CAS  Google Scholar 

  53. Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.

    Article  PubMed  CAS  Google Scholar 

  54. Lupski, J. R., Reid, J. G., Gonzaga-Jauregui, C., Rio, D. D., Chen, D. C., Nazareth, L., et al. (2010). Whole-genome sequencing in a patient with Charcot–Marie–Tooth neuropathy. The New England Journal of Medicine, 362, 1181–1191.

    Article  PubMed  CAS  Google Scholar 

  55. Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375, 1525–1535.

    Article  PubMed  CAS  Google Scholar 

  56. Kohane, I. S., Masys, D. R., & Altman, R. B. (2006). The incidentalome: A threat to genomic medicine. Journal of the American Medical Association, 296, 212–215.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by grants from the US National Institutes of Health (U01 HL65962, RC2 GM092618, U01 HG04603).

Conflicts of interest

Dr. Roden is a consultant to Sanofi-Aventis, one of the sponsors of the meeting at which this work was presented. Dr. Roden retained full control of this manuscript throughout its generation; as this is a review, there are no primary data.

Author information

Authors and Affiliations

  1. Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, 1285 Medical Research Building IV, Nashville, TN, 37232-0575, USA

    Dan M. Roden

Authors
  1. Dan M. Roden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dan M. Roden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roden, D.M. Personalized medicine and the genotype–phenotype dilemma. J Interv Card Electrophysiol 31, 17–23 (2011). https://doi.org/10.1007/s10840-011-9561-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-011-9561-5

Keywords

Search

Navigation